NASDAQ:TVTX

Travere Therapeutics Stock Forecast

etoro logo Buy TVTX
*Your capital is at risk
$55.95
+0.84 (+1.52%)
At Close: Jun 23, 2026
AI Analysis AI Analysis of TVTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TVTX to Watchlist?
Some Reasons Why To Add TVTX:
  • +267.1% price growth over the last year
  • High gross margin of 94.0%
  • Low bankruptcy risk (Altman Z-Score: 4.32)
PDF

Stronger technical forecast for Travere Therapeutics, Inc. stock price after Tuesday trading
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Apr 15, 2026 Gain 36.63%

The Travere Therapeutics, Inc. stock price gained 1.52% on the last trading day (Tuesday, 23rd Jun 2026), rising from $55.11 to $55.95. During the last trading day the stock fluctuated 3.46% from a day low at $54.13 to a day high of $56.01. The price has risen in 7 of the last 10 days and is up by 18.84% over the past 2 weeks. Volume fell on the last day by -161 thousand shares and in total, 2 million shares were bought and sold for approximately $88.49 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 65.49% during the next 3 months and, with a 90% probability hold a price between $80.01 and $100.52 at the end of this 3-month period.

TVTX Signals & Forecast

Mostly positive signals in the chart today. The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $54.22 and $46.81. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 30.24%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

Travere Therapeutics, Inc. finds support from accumulated volume at $55.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.88 between high and low, or 3.46%. For the last week, the stock has had daily average volatility of 3.59%.

The Travere Therapeutics, Inc. stock is extremely overbought on RSI14 (85). This increases the short-term risk substantially.

Our recommended stop-loss: $54.38 (-2.80%) (This stock has high daily movements and this gives high risk. The RSI14 is 85 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Travere Therapeutics, Inc. to open at $55.36, and during the day (based on 14 day Average True Range), to move between $54.81 and $57.09, which gives a possible trading interval of +/-$2.27 (+/-4.15%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.15% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $55.15, some $0.80 (1.43%) from the current price of $55.95, our system finds the risk reward attractive.

Is Travere Therapeutics, Inc. stock A Buy?

Travere Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.932 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $55.36 ( 1.05%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TVTX Performance

Trading levels for TVTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 57.24 2.30%
R2 56.52 1.02%
R1 56.08 0.229%
Price 55.95
S1 54.65 -2.33%
S2 54.20 -3.12%
S3 53.49 -4.40%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 55.95
S1 55.15 -1.43%
S2 42.66 -23.75%
S3 42.13 -24.70%

FAQ

What is the symbol for Travere Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Travere Therapeutics, Inc. is TVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Travere Therapeutics, Inc. Stock?
Travere Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Travere Therapeutics, Inc. Stock?
Travere Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.

What's the current price of Travere Therapeutics, Inc. Stock?
As of the end of day on the Jun 23, 2026, the price of an Travere Therapeutics, Inc. (TVTX) share was $55.95.

What is the 52-week high and low for Travere Therapeutics, Inc. Stock?
The 52-week high for Travere Therapeutics, Inc. Stock is $56.81 and the 52-week low is $13.98.

What is the market capitalization of Travere Therapeutics, Inc. Stock?
As of the Jun 23, 2026, the market capitalization of Travere Therapeutics, Inc. is 5.203B.

When is the next earnings date for Travere Therapeutics, Inc.?
The upcoming earnings date for Travere Therapeutics, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT TRAVERE THERAPEUTICS, INC.
Travere Therapeutics
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzy...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE